Cipla starts rapid antigen test units for identifying Covid-19

Cipla starts rapid antigen test units for identifying Covid-19

Pharmaceutical major Cipla Limited on Wednesday declared its association with the Premier Medical Corporation Private Limited for commercialisation of the quick antigen test units to distinguish Coronavirus sickness (Covid-19) in India that will identify the viral illness in pretty much 15-20 minutes. The organization will begin providing the units from this week, it said in

countinue reading
, ,